Advertisement
Singapore markets closed

  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     

  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • Bitcoin USD

    63,887.41
    -774.32 (-1.20%)
     

  • CMC Crypto 200

    1,333.98
    -62.55 (-4.48%)
     

  • S&P 500

    5,109.63
    +61.21 (+1.21%)
     

  • Dow

    38,287.68
    +201.88 (+0.53%)
     

  • Nasdaq

    15,953.44
    +341.68 (+2.19%)
     

  • Gold

    2,350.50
    +8.00 (+0.34%)
     

  • Crude Oil

    83.77
    +0.20 (+0.24%)
     

  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     

  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     

  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     

  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Progenics: 2Q Earnings Snapshot

Progenics: 2Q Earnings Snapshot

Associated Press

NEW YORK (AP) _ Progenics Pharmaceuticals Inc. (PGNX) on Tuesday reported a loss of $15.2 million in its second quarter.

On a per-share basis, the New York-based company said it had a loss of 20 cents.

The biopharmaceutical company posted revenue of $3.9 million in the period.

Progenics shares have risen 34 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $7.99, an increase of 32 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PGNX at https://www.zacks.com/ap/PGNX